Pratyusha Bala

Affiliations: 
2021-2024 Medical Oncology Dana-Farber Cancer Institute, Boston, MA, United States 
Google:
"Pratyusha Bala"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang F, Sahu V, Peng K, et al. (2024) Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut
Spisak S, Chen D, Likasitwatanakul P, et al. (2024) Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system. Nature Communications. 15: 2230
Spisak S, Chen D, Likasitwatanakul P, et al. (2024) Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. Biorxiv : the Preprint Server For Biology
Sahgal P, Patil DT, Bala P, et al. (2023) Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. Iscience. 26: 108169
Bala P, Rennhack JP, Aitymbayev D, et al. (2023) Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science Advances. 9: eadf0927
Bala P, Kavadipula P, Sarkar S, et al. (2022) To β or Not to β: Lack of Correlation Between APC Mutation and β-Catenin Nuclear Localization in Colorectal Cancer. Journal of Gastrointestinal Cancer
Tanton H, Sewastianik T, Seo HS, et al. (2022) A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science Advances. 8: eabm3108
Liang X, Duronio GN, Yang Y, et al. (2021) An enhancer-driven stem cell-like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer. Gastroenterology
Bala P, Singh AK, Kavadipula P, et al. (2020) Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Oncogene
Bashyam MD, Animireddy S, Bala P, et al. (2019) The Yin and Yang of cancer genes. Gene. 704: 121-133
See more...